News: Public Health

The anthrax antitoxin obiltoxaximab received approval March 21 from the U.S. Food and Drug Administration (FDA).

What do you do when the bacteria you study that's deadly in the real world acts all mild and gentle in the lab?

Richard Finnell studies the genetic underpinnings of neural tube defects such as spina bifida.

Experts at UT Austin share what science says about how students can stay sharp during busy times.

The award recognizes faculty members who have achieved a consistent level of excellence in teaching undergraduate students.